Merits, named ”Sun-Shun Industrial Co., Ltd.” originally, was established in July 1987 and located at Ta-Ya township of Taichung county with 20 employees. In 1992, along with increasing productivity, it moved to Taichung Industrial Park and changed the name to “Merits Health Products Co., Ltd.” with turnover over US$8 million dollars – 25 times the amount of the beginning period. Merits keep growing speedily by updating the quality repeatedly, developing new products constructively and meeting the needs of market continuously. Now, the turnover is over US$100 million dollars with over 500 employees.We moved to The Taichung City Precision Machinery Innovation Technology Park on January 2012.
While established U.S. offices and warehouses in Florida, Texas and California to serve our customer directly in US market and promote products by local agencies through the North & South America, Merits, in the same time, specialized in serving OEM and ODM customers worldwide especially in Europe and America.
Setting the design and production headquarter in Taiwan and Shanghai , Merits organized professional R&D teams and most advanced & precise equipments in this industry. We are one of the largest power mobility manufactures in the world with over 15% market share worldwide. Merits products have been certified by most strict international standards like TUV, ISO, FDA (USA), CE(Europe), and JIS(Japan). In Taiwan, Merits is the fist manufacture inspected by FDA personally; moreover, our outstanding quality has become the key guarantee to satisfy our well-known customers globally.
Merits manufactures Home Medical Equipment mainly for aged and disabled people. All Merits staff are with four sincere hearts, Love, Faithfulness, Carefulness and Determination, when producing high quality and valuable products.
The Vice President of Merits Health Products discusses the company’s main opportunities and challenges of the past 25 years, which countries are among its top buyers and its future plans…
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
In an important milestone for Taiwan’s biotech industry, Diamond Biofund – one of the territory’s most well-established venture capital (VC) funds – became the first such firm to list on…
The latest pharma news from Taiwan, including Gongwin-KY’s lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan’s Industrial Technology Research Institute (ITRI) and Metagone Biotech’s glaucoma and macular…
The latest healthcare and pharma news from Taiwan, including the CDMO Bora Pharmaceutical’s acquisition of Eden Biologics assets, the FDA fast track granted to the Taiwanese biomedical group United Biomedical’s…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what MVC’s competitive advantages are. At MVC we have…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how it differs from sequencing technologies in terms of cost and speed,…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious internationalization plans, and comments on the vital role that companies like Leadgene have…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s rapid and coordinated response to the COVID-19 crisis and also explains how Quark Biosciences’ diagnostics and precision…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market, rising medical needs in Asia are helping foster more regionally-focused strategies. …
All country managers of multinational pharma companies need to strike the balance between having a global outlook and adapting to local culture. For BoonHuey Ee, general manager of Merck Biopharma…
See our Cookie Privacy Policy Here
